Moderna said last week that the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, offering a glimmer of hope for a vaccine among the most advanced in development.Moderna extends lipids deal to boost COVID-19 vaccine output
Moderna said last week that the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, offering a glimmer of hope for a vaccine among the most advanced in development.
Subscribe to:
Post Comments (Atom)
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
-
Market-men said the fall in gold prices at futures trade was mostly due to trimming of positions by participants.
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
No comments:
Post a Comment